# Cell Therapy for Corneal Endothelial Cell Dysfunction

> **NCT06726174** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Corneal Endothelial Cell Dysfunction

## Interventions

- **DRUG:** ECCEC

## Key facts

- **NCT ID:** NCT06726174
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-25
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06726174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06726174, "Cell Therapy for Corneal Endothelial Cell Dysfunction". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06726174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*